NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Both Mexico and Canada have been subject to tariffs and tariff threats from U.S. President Donald Trump since he was re-elected.Read More